NCT04268849View on ClinicalTrials.gov

Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

PHASE3RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

February 28, 2026

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferumoxytol

Ferumoxytol (30 mg/mL) intravenous injection in single use vials.

DRUG

Saline

Placebo for Ferumoxytol

DRUG

Ferrous sulfate tablets

ferrous sulfate tablets containing 60 mg elemental iron

DRUG

Vitamin C

Placebo: Vitamin C, 250 mg, given in the same bottle as the oral iron

Trial Locations (1)

21237

RECRUITING

Auerbach Hematology and Oncology, Baltimore

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

Auerbach Hematology Oncology Associates P C

OTHER